Cite
MLA Citation
Rachel S Kerr et al.. “Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial.” Lancet oncology, vol. 17, no. 11, n.d., pp. 1543–1557. http://access.bl.uk/ark:/81055/vdc_100038840370.0x000033